Maria E. Arcila, MD

About Me

I am an anatomic and clinical pathologist who specializes in molecular genetic pathology and hematology.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

As a molecular genetic pathologist, my work primarily involves the study and detection of genetic changes in cancer tissue. These changes can be used to diagnose and confirm the presence of individual cancer types and help tailor patient-specific treatment, determine patients’ prognosis and risk of recurrence, and monitor their disease once they start therapy. As a hematopathologist, I work closely with our clinical colleagues to diagnose diseases that affect the blood and the lymphoid systems. I directly examine tissue and blood samples to diagnose, stage, and monitor hematologic cancers including leukemia, lymphoma, myeloma, and other diseases at both the morphologic and the molecular levels.

My research is focused on the molecular changes that fuel the development of lung carcinoma and the search for possible therapeutic and prognostic markers in patients with this disease. Because of this interest, I have become directly involved with the expansion, validation, and implementation of clinical tests at Memorial Sloan Kettering to detect mutations relevant to the management and treatment of patients with lung carcinoma.

In addition to my clinical interests, I am a medical illustrator.

  • Clinical Expertise: Molecular Genetic Pathology; Hematopathology; Anatomic and Clinical Pathology
  • Languages Spoken: English
  • Education: M.D., University of Pittsburgh School of Medicine
  • Residencies: Tripler Army Medical Center; Madigan Army Medical Center
  • Fellowships: Memorial Sloan Kettering Cancer Center
  • Board Certifications: Molecular Genetic Pathology; Hematology; Anatomic and Clinical Pathology


Visit PubMed for a full listing of Maria E. Arcila’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.